SHINE 2Europe partner in a new Horizon project that will involve 720 patients with liver cancer
Liver cancer is the fifth most frequent worldwide and the second most deadly, with about 750,000 cases per year. In addition, liver cancer has a high chance of recurrence, even after surgery. The prevalence of local recurrence after resection of hepatocellular carcinoma is 20% or more. But is it possible that an additional innovative technique …
